RT Journal Article SR Electronic T1 Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes JF Evidence Based Medicine JO Evid Based Med FD BMJ Publishing Group Ltd SP 122 OP 123 DO 10.1136/ebm1412 VO 16 IS 4 A1 Yves Lacourcière A1 Luc Poirier YR 2011 UL http://ebm.bmj.com/content/16/4/122.abstract AB